InvestorsHub Logo
Followers 118
Posts 20262
Boards Moderated 0
Alias Born 06/13/2011

Re: rosemountbomber post# 386139

Friday, 08/12/2022 7:55:25 PM

Friday, August 12, 2022 7:55:25 PM

Post# of 424049
Ahh. RMB … we are forward looking here

If … and that’s IF … MITIGATE and RESPECT trials show significant clinical risk reduction AND AMRN can launch a new once a day Vascepa formulation with at least 3 yrs exclusivity…that’s less expensive then GV ….. where do U see the stock going ?

Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News